Tsvetkov P., Coy S., Petrova B., Dreishpoon M., Verma A., Abdusamad M., Rossen J., Joesch-Cohen L., Humeidi R., Spangler R.D., Eaton J.K., Frenkel E., Kocak M., Corsello S.M., Lutsenko S., Kanarek N., Santagata S., Golub T.R. 2022. Copper induces cell death by targeting lipoylated TCA cycle proteins. Science. 375, 1254–1261.
Article CAS PubMed PubMed Central Google Scholar
Hu J., Yan L., Cao Z., Geng B., Cao X., Liu B., Guo J., Zhu J. 2024. Tumor microenvironment activated cu crosslinked near-infrared sonosensitizers for visualized cuproptosis-enhanced sonodynamic cancer immunotherapy. Adv. Sci. (Weinheim, Ger.) 11, e2407196.
Luo Z., Lu R., Shi T., Ruan Z., Wang W., Guo Z., Zhan Z., Ma Y., Lian X., Ding C., Chen Y. 2024. Enhanced bacterial cuproptosis-like death via reversal of hypoxia microenvironment for biofilm infection treatment. Adv. Sci. (Weinheim, Ger.) 11, e2308850.
Shi J.X., Zhang Z.C., Yin H.Z., Piao X.J., Liu C.H., Liu Q.J., Zhang J.C., Zhou W.X., Liu F.C., Yang F., Wang Y.F., Liu H. 2024. RNA m6A modification in ferroptosis: implications for advancing tumor immunotherapy. Mol. Cancer. 23, 213.
Article PubMed PubMed Central Google Scholar
Bu F.T., Wang H.Y., Xu C., Song K.L., Dai Z., Wang L.T., Ying J., Chen J. 2024. The role of m6A-associated membraneless organelles in the RNA metabolism processes and human diseases. Theranostics. 14, 4683–4700.
Article CAS PubMed PubMed Central Google Scholar
Li F., Zeng C., Liu J., Wang L., Yuan X., Yuan L., Xia X., Huang W. 2024. The YTH domain-containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets. Clin. Transl. Med. 14, e1784.
Article CAS PubMed PubMed Central Google Scholar
Fernandez Rodriguez G., Tarullo M., Fatica A. 2024. N6-methyladenosine (m6A) RNA modification in chronic myeloid leukemia: Unveiling a novel therapeutic target. Cell. Mol. Life Sci. 81, 326.
Article CAS PubMed PubMed Central Google Scholar
Liu X., Wang H., Zhao X., Luo Q., Wang Q., Tan K., Wang Z., Jiang J., Cui J., Du E., Xia L., Du W., Chen D., Xia L., Xiao S. 2021. Arginine methylation of METTL14 promotes RNA N6-methyladenosine modification and endoderm differentiation of mouse embryonic stem cells. Nat. Commun. 12, 3780.
Article CAS PubMed PubMed Central Google Scholar
Jin K.X., Zuo R., Anastassiadis K., Klungland A., Marr C., Filipczyk A. 2021. N6-methyladenosine (m6A) depletion regulates pluripotency exit by activating signaling pathways in embryonic stem cells. Proc. Natl. Acad. Sci. U. S. A. 118, e2105192118.
Article CAS PubMed PubMed Central Google Scholar
Zhang J., Liu X., Gao Y. 2024. FTO protein regulates the TGF-β signalling pathway through RNA N6-methyladenosine modification to induce unexplained recurrent spontaneous abortion. FEBS J. 291, 1545–1559.
Article CAS PubMed Google Scholar
Xiaorong Y., Lu X., Fangyue X., Chao X., Jun G., Qiang W. 2024. Integrated multiomics characterization reveals cuproptosis-related hub genes for predicting the prognosis and clinical efficacy of ovarian cancer. Front. Immunol. 15, 1452294.
Article PubMed PubMed Central Google Scholar
Yi N., Zhang L., Huang X., Ma J., Gao J. 2025. Lenvatinib-activated NDUFA4L2/IL33/PADI4 pathway induces neutrophil extracellular traps that inhibit cuproptosis in hepatocellular carcinoma. Cell. Oncol. 48, 487–504.
Li Y., Han Y., Shu Q., Kan Y.K., Wang Z. 2025. Cuproptosis and copper as potential mechanisms and intervention targets in Alzheimer’s disease. Biomed. Pharmacother. 183, 117814.
Article CAS PubMed Google Scholar
Tsui K.H., Li C.J., Lin L.T. 2024. Melatonin supplementation attenuates cuproptosis and ferroptosis in aging cumulus and granulosa cells: Potential for improving IVF outcomes in advanced maternal age. Reprod. Biol. Endocrinol. 22, 138.
Article CAS PubMed PubMed Central Google Scholar
Zheng Z., Fang J., Shen Y., Mi C., Xu Z., Zhao J., Chen W., Han R., Lei Q., Zhang H. 2024. Copper exposure induces trophoblast cell cuproptosis by up-regulating lnc-HZ11. Ecotoxicol. Environ. Saf. 281, 116641.
Article CAS PubMed Google Scholar
Shen X.Y., Huang J., Chen L.L., Sha M.T., Gao J., Xin H. 2024. Blocking lactate regulation of the Grhl2/SLC31A1 axis inhibits trophoblast cuproptosis and preeclampsia development. J. Assisted Reprod. Genet. 41, 3201–3212.
Zhao J., Xu Z., Wang X., Wan S., Chen W., Huang W., Wang M., Wang R., Zhang H. 2024. Environmental copper exposure, placental cuproptosis, and miscarriage. Environ. Pollut. 348, 123847.
Article CAS PubMed Google Scholar
Wang Y., Li Y., Skuland T., Zhou C., Li A., Hashim A., Jermstad I., Khan S., Dalen K.T., Greggains G.D., Klungland A., Dahl J.A., Au K.F. 2023. The RNA m6A landscape of mouse oocytes and preimplantation embryos. Nat. Struct. Mol. Biol. 30, 703–709.
Article CAS PubMed PubMed Central Google Scholar
Yao H., Gao C.C., Zhang D., Xu J., Song G., Fan X., Liang D.B., Chen Y.S., Li Q., Guo Y., Cai Y.T., Hu L., Zhao Y.L., Sun Y.P., Yang Y., Han J., Yang Y.G. 2023. scm6A-seq reveals single-cell landscapes of the dynamic m6A during oocyte maturation and early embryonic development. Nat. Commun. 14, 315.
Article CAS PubMed PubMed Central Google Scholar
Zhu Y., Wu W., Chen S., Zhang Z., Zhang G., Li J., Jiang M. 2022. Mettl3 downregulation in germinal vesicle oocytes inhibits mRNA decay and the first polar body extrusion during maturation. Biol. Reprod. 107, 765–778.
Sui X., Hu Y., Ren C., Cao Q., Zhou S., Cao Y., Li M., Shu W., Huo R. 2020. METTL3-mediated m6A is required for murine oocyte maturation and maternal-to-zygotic transition. Cell Cycle. 19, 391–404.
Article CAS PubMed PubMed Central Google Scholar
Mu H., Zhang T., Yang Y., Zhang D., Gao J., Li J., Yue L., Gao D., Shi B., Han Y., Zhong L., Chen X., Wang Z.B., Lin Z., Tong M.H., Sun Q.Y., Yang Y.G., Han J. 2021. METTL3-mediated mRNA N6-methyladenosine is required for oocyte and follicle development in mice. Cell Death Dis. 12, 989.
Article CAS PubMed PubMed Central Google Scholar
Lin Z., Hsu P.J., Xing X., Fang J., Lu Z., Zou Q., Zhang K.J., Zhang X., Zhou Y., Zhang T., Zhang Y., Song W., Jia G., Yang X., He C., Tong M.H. 2017. Mettl3−/Mettl14-mediated mRNA N6-methyladenosine modulates murine spermatogenesis. Cell Res. 27, 1216–1230.
Article CAS PubMed PubMed Central Google Scholar
Xue P., Zhou W., Fan W., Jiang J., Kong C., Zhou W., Zhou J., Huang X., Yang H., Han Q., Zhang B., Xu L., Yu B., Chen L. 2021. Increased METTL3-mediated m6A methylation inhibits embryo implantation by repressing HOXA10 expression in recurrent implantation failure. Reprod. Biol. Endocrinol. 19, 187.
Article CAS PubMed PubMed Central Google Scholar
Wan W., Ao X., Chen Q., Yu Y., Ao L., Xing W., Guo W., Wu X., Pu C., Hu X., Li Z., Yao M., Luo D., Xu X. 2022. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Mol. Cancer. 21, 60.
Article CAS PubMed PubMed Central Google Scholar
Zhang Y., Yang H., Long Y., Zhang Y., Chen R., Shi J., Chen J. 2021. circRNA N6-methyladenosine methylation in preeclampsia and the potential role of N6-methyladenosine-modified circPAPPA2 in trophoblast invasion. Sci. Rep. 11, 24357.
Article CAS PubMed PubMed Central Google Scholar
Li W., Liu D., Chang W., Lu X., Wang Y.L., Wang H., Zhu C., Lin H.Y., Zhang Y., Zhou J., Wang H. 2014. Role of IGF2BP3 in trophoblast cell invasion and migration. Cell Death Dis. 5, e1025.
Comments (0)